课题基金 / 基金详情

STUDY OF NUCLEOTIDE SEQUENCES ENCODING ANTIGENIC SITES

STUDY OF NUCLEOTIDE SEQUENCES ENCODING ANTIGENIC SITES
编码抗原位点的核苷酸序列的研究
批准号:
3444591
负责人:
WILLIAM H WUNNER
金额:
$13.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-03-01 至 1988-02-29

项目摘要

项目成果

WILLIAM H WUNNER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The continued study of rabies virus glycoprotein antigenic sites will concentrate on the location of single amino acid changes in the glycoprotein of antigenic variants which differentiate epitopes involved in the binding of virus-neutralizing antibodies. Comparative nuecleotide sequence analysis will identify mutations in variant glycoprotein genes which express antigenically altered glycoproteins. This will be accomplished by using synthetic DNA primers in primer extension experiments to obtain complementary DNA transcripts from virion RNA templates isolated from the antigenic variant viruses. Amino acid substitutions deduced from the altered nucleotide sequences will be correlated with the grouping of epitopes in the functional epitope maps of two fixed rabies virus strain glycoproteins. This study will be extended to compare antigenic determinants of fixed virus with street rabies virus glycoproteins. The topographic relationship of amino acids associated with the different epitopes in the rabies virus glycoprotein will be determined based on (a) the linear distribution of residue changes deduced from nucleotide sequence analysis, and (b) the effect of substituted residues induced by site-directed mutagenesis of the cloned glycoprotein gene. The significance of the induced change as a local perturbation of the antigenic structure will be evaluated. Conformational and/or linear alterations in the structure of the glycoprotein derived from the mutated gene will be characterized by its ability to bind monoclonal antibodies. Finally, the nucleotide sequence of a cloned rabies virus nucleoprotein double-stranded complementary DNA will be determined, and the sequences encoding antigenic sites will be investigated. Antigenic variations reflected by differences in chemical structure of the two major antigens (nucleoprotein and glycoprotein) will define limitations of effective vaccine prophylaxis and post-exposure treatment.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Nucleotide and deduced amino acid sequences of the nominal nonstructural phosphoprotein of the ERA, PM and CVS-11 strains of rabies virus.
狂犬病病毒 ERA、PM 和 CVS-11 株名义非结构磷蛋白的核苷酸序列和推导的氨基酸序列。
DOI: 10.1093/nar/18.23.7172
发表时间: 1990
期刊: Nucleic acids research
影响因子: 14.9
作者: [Larson,JK, Wunner,WH]
通讯作者: Wunner,WH
Detection of rabies virus genomic RNA and mRNA in mouse and human brains by using in situ hybridization.
使用原位杂交检测小鼠和人脑中狂犬病病毒基因组 RNA 和 mRNA。
DOI: 10.1128/jvi.65.6.2839-2844.1991
发表时间: 1991
期刊: Journal of virology
影响因子: 5.4
作者: [Jackson,AC, Wunner,WH]
通讯作者: Wunner,WH
CORE--EXPRESSION VECTOR/RECOMBINANT PROTEIN PRODUCTION FACILITY
  • 批准号:
    6429982
  • 项目类别:
  • 资助金额:
    $22.01万
  • 财政年份:
    2001
  • 负责人:
    WILLIAM H WUNNER
  • 依托单位:
CORE--EXPRESSION VECTOR/RECOMBINANT PROTEIN PRODUCTION FACILITY
  • 批准号:
    6312717
  • 项目类别:
  • 资助金额:
    $22.01万
  • 财政年份:
    2000
  • 负责人:
    WILLIAM H WUNNER
  • 依托单位:
CORE--EXPRESSION VECTOR/RECOMBINANT PROTEIN PRODUCTION FACILITY
  • 批准号:
    6299945
  • 项目类别:
  • 资助金额:
    $16.05万
  • 财政年份:
    2000
  • 负责人:
    WILLIAM H WUNNER
  • 依托单位:
CORE--EXPRESSION VECTOR/RECOMBINANT PROTEIN PRODUCTION FACILITY
  • 批准号:
    6101454
  • 项目类别:
  • 资助金额:
    $16.05万
  • 财政年份:
    1999
  • 负责人:
    WILLIAM H WUNNER
  • 依托单位:
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: